German drug and chemical manufacturer Bayer said on Thursday the number of plaintiffs in a lawsuit relating to its Baycol anti-cholesterol drug has increased to 7,400. More than 100 deaths have been linked the controversial drug, which the company recalled in 2001. As of November, only 5,700 had lined up to sue the company. A Bayer spokeswoman said the company has reached settlements with 400 people. In many countries, the drug was sold under the name Lipobay.